- Beyond (NASDAQ:BYND) launched Beyond Steak Filet at Wegmans and H-E-B, marking the product’s first retail availability after becoming its top-selling item online
- The company continues to face significant financial challenges, with 2025 revenue and gross profit declining sharply amid weak demand and ongoing losses
- Beyond is also dealing with a Nasdaq delisting warning, a shareholder lawsuit, and a corporate rebrand as it seeks to expand beyond plant-based meat into broader protein categories
- Beyond Meat stock (NASDAQ:BYND) last traded at $0.71
Beyond Meat (NASDAQ:BYND), now operating under the name Beyond the Plant Protein Company, has announced the retail debut of its Beyond Steak Filet, now available at Wegmans and H-E-B stores across the United States.
The launch marks the first time consumers can purchase the whole-cut plant-based steak product through traditional retail channels, representing an important milestone in the company’s efforts to reinvigorate growth and broaden its product portfolio.
This article is a journalistic opinion piece that has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
The retail rollout follows a successful direct-to-consumer launch in October 2025, when Beyond Steak Filet was introduced through the company’s online platform. Since then, the product has quickly become the company’s top-selling item on its website, with consumers highlighting its taste, texture and nutritional profile as key differentiators in an increasingly competitive plant-based protein market.
Designed to replicate the experience of a premium steak, Beyond Steak Filet is made with mycelium and avocado oil and contains 28 grams of plant protein, 3 grams of fibre, and only 1 gram of saturated fat per serving. The company says the product delivers a tender, juicy texture while maintaining a simple ingredient list that aligns with growing consumer demand for minimally processed foods.
The new offering also carries several certifications intended to appeal to health-conscious shoppers. Beyond Steak Filet is among more than 20 products in the company’s portfolio that have earned Clean Label Project Certification, recognizing products that meet rigorous standards for purity and transparency. The product is additionally Non-GMO Project Verified and contains no added antibiotics or hormones.
The launch comes as Beyond continues efforts to diversify its product lineup beyond its traditional plant-based burger and sausage offerings. Management has increasingly emphasized innovation and product quality as central pillars of its strategy to revive demand amid slower growth across the broader plant-based meat category.
However, the positive reception surrounding Beyond Steak Filet stands in contrast to the significant financial and operational challenges the company continues to face.
Compliments to the chef?
“I believe Beyond Steak Filet is our most compelling centre-of-the-plate innovation since the Beyond Burger,” Ethan Brown (no relation), Beyond’s founder and CEO said in a news release. “The product marks the introduction of the powerhouse ingredient mycelium into our portfolio and delivers 28g of clean protein with just 1g of saturated fat from avocado oil.”
Revenue declines persist
Beyond Meat’s most recent financial results underscore the difficult environment confronting the business.
For the fourth quarter of 2025, the company reported net revenues of US$61.6 million, representing a 19.7 per cent decline year-over-year. Gross profit fell sharply to US$1.4 million, resulting in a gross margin of 2.3 per cent, down from gross profit of US$10.0 million and a gross margin of 13.1 per cent during the same period a year earlier.
The full-year picture was similarly challenging. For fiscal 2025, net revenues totaled US$275.5 million, a decrease of 15.6 per cent compared to fiscal 2024. Gross profit dropped to US$7.6 million, producing a gross margin of just 2.8 per cent, compared with US$41.7 million and a gross margin of 12.8 per cent in the previous year.
The figures highlight the ongoing pressure facing the company as demand for plant-based meat products remains weak across many markets, while production costs, competitive dynamics and consumer adoption trends continue to weigh on profitability.
NASDAQ delisting threat adds pressure
Adding to investor concerns, Beyond Meat recently received a NASDAQ deficiency notice after its shares traded below the exchange’s minimum US$1.00 bid-price requirement for 30 consecutive business days.
According to a March 6 filing with the U.S. Securities and Exchange Commission, NASDAQ’s Listing Qualifications Department notified the company on March 4 that it had fallen out of compliance with listing standards. While the notice does not immediately impact trading and shares continue to trade under the BYND ticker, it places additional pressure on management to stabilize the stock price.
Beyond Meat’s shares have spent much of 2026 below the US$1 threshold, recently trading around US$0.79, reflecting a decline of approximately 76 per cent over the past year. The company has yet to report an annual profit since its highly publicized 2019 initial public offering.
Under NASDAQ rules, Beyond has until August 31, 2026, to regain compliance by maintaining a closing share price of at least US$1 for a minimum of ten consecutive trading days. Should it fail to meet that requirement, the company could pursue an additional 180-day extension by transferring to the NASDAQ Capital Market and satisfying other listing criteria.
One potential path forward is a reverse stock split, a strategy already authorized by shareholders in November 2025. The authorization provides the board with flexibility to implement a reverse split ratio if deemed necessary to restore compliance.
Debt restructuring and asset impairments
The company’s stock performance has also been affected by broader balance-sheet concerns. During late 2025, Beyond completed a debt exchange that eliminated more than US$800 million of debt, improving leverage but at the cost of increased interest expenses and shareholder dilution.
At the same time, the company recorded a US$77.4 million impairment charge tied to long-lived assets and the winding down of its China operations. Additional legal and arbitration-related expenses further weighed on results.
The combination of declining sales, impairment charges and restructuring costs has contributed to a prolonged period of investor skepticism regarding the company’s long-term turnaround prospects.
Rebranding Beyond Meat to “Beyond”
As the company navigates these challenges, it is also attempting to reshape its identity.
Last week, the El Segundo, California-based business officially dropped “Meat” from its corporate branding, adopting the name Beyond The Plant Protein Co., or simply Beyond. The company’s website and social media channels have already been updated to reflect the new branding.
Chief Executive Officer Ethan Brown described the move as part of a broader effort to position the company around what he called “very real food that is directly from plants.” The rebrand signals ambitions to expand beyond plant-based meat substitutes into adjacent categories such as protein beverages and snacks.
Among the first examples of that expansion is the recently launched Beyond Immerse sparkling protein drink. Management has indicated that additional plant-derived protein products could be introduced later this year.
Class action lawsuit raises additional concerns
Further complicating the outlook, Beyond and certain senior executives are facing a securities class action lawsuit filed in the U.S. District Court for the Central District of California.
The lawsuit was brought on behalf of investors who purchased securities between February 27, 2025, and November 11, 2025. The complaint alleges violations of the Securities Exchange Act of 1934, claiming that the company made misleading statements regarding the valuation of certain long-lived assets.
According to the filing, those assets ultimately required significant impairment charges, contributing to delayed SEC filings and several sharp declines in the company’s stock price. The suit centers on disclosures that culminated in the company’s reported US$77.4 million impairment charge.
A critical period ahead
The retail launch of Beyond Steak Filet represents a rare bright spot for Beyond as it seeks to demonstrate that consumer demand still exists for innovative, plant-based protein products. Early customer reception and strong direct-to-consumer sales suggest the product may resonate with shoppers looking for healthier and more sustainable alternatives to traditional beef.
Nevertheless, investors are likely to remain focused on the company’s broader financial challenges, including declining revenues, razor-thin margins, delisting risk, legal proceedings and the need to establish a sustainable path to profitability.
Whether the commercial success of products such as Beyond Steak Filet can help offset those headwinds remains one of the key questions facing Beyond and its shareholders in the months ahead.
Order up
Plant-based meat company, Beyond Meat Inc. engages in the development, manufacture, marketing, and sale of plant-based meat products under the Beyond brand name in the United States and internationally. The company sells a range of plant-based meat products that replicates beef, pork, and poultry meats.
Beyond Meat stock (NASDAQ:BYND) closed more than 4 per cent lower on Thursday at $0.71 and has lost nearly 80 per cent since this time last year. While BYND stock is trending downward since the year began, it has seen some upward momentum over the past three months.
Join the discussion: Find out what the Bullboards are saying about Beyond Meat and check out Stockhouse’s stock forums and message boards.
